ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd (VM)

0,19
0,02
(11,76%)
Geschlossen 26 Januar 10:00PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
0,19
Gebot
0,185
Fragen
0,19
Volumen
907.850
0,17 Tagesbereich 0,20
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
0,17
Handelsbeginn
0,175
Letzte Trade
1000
@
0.19
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
132.702.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-18,10
Gewinn pro Aktie (EPS)
-0,01
Erlöse
-
Nettogewinn
-1,4M

Über Voyageur Pharmaceuticals Ltd

Sektor
Minrls,earths-ground,treated
Branche
Unit Inv Tr, Closed-end Mgmt
Hauptsitz
Calgary, Alberta, Can
Gegründet
2020
Voyageur Pharmaceuticals Ltd is listed in the Minrls,earths-ground,treated sector of the TSX Venture Börse with ticker VM. The last closing price for Voyageur Pharmaceuticals was $0,17. Over the last year, Voyageur Pharmaceuticals shares have traded in a share price range of $ 0,00 to $ 0,00.

Voyageur Pharmaceuticals currently has 132.702.000 shares in issue. The market capitalisation of Voyageur Pharmaceuticals is $22,56 million. Voyageur Pharmaceuticals has a price to earnings ratio (PE ratio) of -18.10.

VM Neueste Nachrichten

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Completed Production of a Test Batch of its SmoothX™ Barium Sulfate CT Contrast Media Oral Suspension for the Canadian CT Imaging Market

VANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals (TSXV:VM) (OTCPink:VYYRF) has completed production of a test batch of its SmoothX™ barium sulfate CT...

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Completion of the design of its Carbon Neutral Pharmaceutical Facility and Accelerated Revenue Generation Timeline for its Frances Creek Barium Sulfate Project

VANCOUVER, British Columbia, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals (TSXV:VM) (OTCPink:VYYRF) has completed the design of its carbon neutral pharmaceutical facility resulting...

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ MOU with Rain Cage Carbon to Develop Fullerene-Based Medical Contrast Agents from Carbon Capture of Hydrocarbon Exhaust Systems

VANCOUVER, British Columbia, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals (TSXV:VM) (OTCPink:VYYRF) has signed a memorandum of understanding with Rain Cage Carbon to develop...

InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Notice of Work with the BC Ministry of Mines, for the Removal of 2,000 Tonnes of Barium Sulfate from its Frances Creek Project

VANCOUVER, British Columbia, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals (TSXV:VM) (OTCPink:VYYRF) has submitted a notice of work with the BC Ministry of Mines, for the removal...

Voyageur Secures Exclusive Rights To One Of The Worlds Rarest Pharmaceutical Minerals

  Voyageur Secures Exclusive Rights To One Of The Worlds Rarest Pharmaceutical Minerals, Creating A New Era In Carbon Based Drug Development   Calgary, Alberta: May 11th...

Voyageur Secures Exclusive Rights To One Of The Worlds Rarest Pharmaceutical Minerals, Creating A New Era In Carbon Based Dru...

CALGARY, Alberta, May 11, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce it has signed an LOI with an...

Voyageur Restructures its ImagingX Joint Venture

CALGARY, Alberta, March 20, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM) (the “Company” or “Voyageur”) is pleased to announce the dissolution of the current joint venture...

Voyageur Pharmaceuticals Announces its “From The Earth To The Bottle” Iodine Contrast Strategy

CALGARY, Alberta, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSX.V:VM, USA:VYYRF) (the “Company” or “Voyageur”) is pleased to announce the fully-integrated iodine business...

Voyageur Pharmaceuticals Implements Frances Creek Environmental Strategy for Bulk Sample and Future Quarry Production

Voyageur Pharmaceuticals Implements Frances Creek Environmental Strategy for Bulk Sample and Future Quarry Production CALGARY, Alberta – The Newswire – February 18th...

Voyageur Pharmaceuticals Implements Frances Creek Environmental Strategy for Bulk Sample and Future Quarry Production

CALGARY, Alberta, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Voyageur Pharmaceuticals Ltd. (TSXV:VM) (the "Company" or "Voyageur") is implementing steps to ensure the Frances Creek barium sulfate project...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

VM - Frequently Asked Questions (FAQ)

What is the current Voyageur Pharmaceuticals share price?
The current share price of Voyageur Pharmaceuticals is $ 0,19
How many Voyageur Pharmaceuticals shares are in issue?
Voyageur Pharmaceuticals has 132.702.000 shares in issue
What is the market cap of Voyageur Pharmaceuticals?
The market capitalisation of Voyageur Pharmaceuticals is CAD 22,56M
What is the 1 year trading range for Voyageur Pharmaceuticals share price?
Voyageur Pharmaceuticals has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Voyageur Pharmaceuticals?
The price to earnings ratio of Voyageur Pharmaceuticals is -18,1
What is the reporting currency for Voyageur Pharmaceuticals?
Voyageur Pharmaceuticals reports financial results in CAD
What is the latest annual profit for Voyageur Pharmaceuticals?
The latest annual profit of Voyageur Pharmaceuticals is CAD -1,4M
What is the registered address of Voyageur Pharmaceuticals?
The registered address for Voyageur Pharmaceuticals is SUITE 800, 333 7TH AVENUE SW, CALGARY, ALBERTA, T2P 2Z1
What is the Voyageur Pharmaceuticals website address?
The website address for Voyageur Pharmaceuticals is www.voyageurpharmaceuticals.ca
Which industry sector does Voyageur Pharmaceuticals operate in?
Voyageur Pharmaceuticals operates in the UNIT INV TR, CLOSED-END MGMT sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ADEAdex Mining Inc
$ 0,01
(100,00%)
1.000
DEALPlaygon Games Inc
$ 0,02
(100,00%)
1,75M
TVC.HThree Valley Copper Corp
$ 0,01
(100,00%)
15,6k
GBUGabriel Resources Ltd
$ 0,01
(100,00%)
167k
MACThemac Resources Group Ltd
$ 0,08
(60,00%)
3k
NAVNAVCO Pharmaceuticals Inc
$ 0,005
(-50,00%)
16,63k
SMAR.PSmartset Services Inc
$ 0,015
(-50,00%)
30k
ETUE2gold Inc
$ 0,005
(-50,00%)
101,7k
DDDMetavista3D Inc
$ 2,30
(-49,45%)
701,59k
MXL.HMX Gold Corp
$ 0,04
(-46,67%)
1,5k
NDANeptune Digital Assets Corp
$ 2,20
(30,18%)
5,15M
BRCBlackrock Silver Corp
$ 0,355
(-11,25%)
3,79M
TDGTDG Gold Corp
$ 0,45
(-1,10%)
3,19M
GPUSAlset AI Ventures Inc
$ 0,14
(-12,50%)
2,79M
PNGKraken Robotics Inc
$ 2,87
(0,35%)
2,69M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock